Inventor · disambiguated record
Daniel B. Horne
Also filed as: HORNE DANIEL · HORNE DANIEL B · HORNE DANIEL BRIAN
24 granted patents·5 pending applications·158 citations·filing 2008–2021
95Inventor score
Top patents by PatentIndex Score
29 records- 0198US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0297US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0397US10058550B2Methods of treating heart failureAMGEN INC·Filed 2017·Granted Aug 28, 2018·13 cites·81 claims
- 0497US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0597US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0697US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0795US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 0895US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 0995US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1090US11845744B2Methods and compositions for modulating splicingSKYHAWK THERAPEUTICS INC·Filed 2021·Granted Dec 19, 2023·2 cites·18 claims
- 1182US9096527B2TRPM8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Granted Aug 4, 2015·5 cites·38 claims
- 1280US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 1380US9376450B2Heteroaryloxyheterocyclyl compounds as PDE10 inhibitorsAMGEN INC·Filed 2013·Granted Jun 28, 2016·4 cites·26 claims
- 1479US11332459B2Benzimidazole derivatives and their usesTEIJIN PHARMA LTD·Filed 2018·Granted May 17, 2022·2 cites·16 claims
- 1579US8497265B2Heteroaryloxyheterocyclyl compounds as PDE10 inhibitorsALLEN JENNIFER R·Filed 2011·Granted Jul 30, 2013·4 cites·16 claims
- 1679US8318718B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2009·Granted Nov 27, 2012·4 cites·94 claims
- 1772US7973047B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2010·Granted Jul 5, 2011·2 cites·21 claims
- 1870US8778941B2TRPM8 antagonists and their use in treatmentsBROWN JAMES·Filed 2012·Granted Jul 15, 2014·1 cites·33 claims
- 1960US8163909B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted Apr 24, 2012·0 cites·17 claims
- 2056US8173810B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted May 8, 2012·0 cites·17 claims
- 2155US8710043B2TRPM8 antagonists and their use in treatmentsCHEN JIAN J·Filed 2012·Granted Apr 29, 2014·0 cites·40 claims
- 2255US2023008867A1Methods and compositions for modulating splicingSKYHAWK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2354US2023027684A1Methods and compositions for modulating splicingSKYHAWK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2454US2022048902A1Methods and compositions for modulating splicingSKYHAWK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2552US2014235642A1Trpm8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Application pending·0 cites
- 2648US2015031668A1Chroman derivatives as trpm8 inhibitorsAMGEN INC·Filed 2014·Application pending·0 cites
- 2746US8952009B2Chroman derivatives as TRPM8 inhibitorsAMGEN INC·Filed 2013·Granted Feb 10, 2015·0 cites·57 claims
- 2846US8552181B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2012·Granted Oct 8, 2013·0 cites·12 claims
- 2943US8476297B2TRP-M8 receptor ligands and their use in treatmentsNORMAN MARK H·Filed 2008·Granted Jul 2, 2013·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →